RMEBX
Price
$57.84
Change
-$0.46 (-0.79%)
Updated
Jun 13 closing price
Net Assets
105.76B
TRLCX
Price
$22.87
Change
-$0.22 (-0.95%)
Updated
Jun 13 closing price
Net Assets
6.32B
Interact to see
Advertisement

RMEBX vs TRLCX

Header iconRMEBX vs TRLCX Comparison
Open Charts RMEBX vs TRLCXBanner chart's image
American Funds American Mutual R2E
Price$57.84
Change-$0.46 (-0.79%)
VolumeN/A
Net Assets105.76B
Nuveen Large Cap Value Retire
Price$22.87
Change-$0.22 (-0.95%)
VolumeN/A
Net Assets6.32B
RMEBX vs TRLCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMEBX vs. TRLCX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and TRLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. TRLCX (6.32B). TRLCX pays higher dividends than RMEBX: TRLCX (1.23) vs RMEBX (1.16). RMEBX was incepted earlier than TRLCX: RMEBX (11 years) vs TRLCX (23 years). RMEBX (1.07) is less costly to investors than TRLCX (0.66). RMEBX is a more actively managed with annual turnover of: 31.00 vs. TRLCX (19.00). TRLCX has a lower initial minimum investment than RMEBX: TRLCX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.54 vs. TRLCX (7.41). RMEBX (58.69) and TRLCX (57.56) have equivalent 5 years return.
RMEBXTRLCXRMEBX / TRLCX
Total Expense Ratio1.070.66162%
Annual Report Gross Expense Ratio1.070.66162%
Fund Existence11 years23 years-
Gain YTD5.9234.049146%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets106B6.32B1,676%
Annual Yield % from dividends1.161.2394%
Returns for 1 year8.547.41115%
Returns for 3 years27.8926.91104%
Returns for 5 years58.6957.56102%
Returns for 10 years68.2233.35205%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EHC120.920.74
+0.62%
Encompass Health Corp
BHFAP19.66-0.01
-0.05%
Brighthouse Financial
AMRX7.75-0.21
-2.64%
Amneal Pharmaceuticals
ATAI2.11-0.07
-3.21%
ATAI Life Sciences NV
IMUX0.80-0.04
-4.62%
Immunic